Rat models of myocardial infarction

Ravinay Bhindi; Paul K. Witting; Aisling C. McMahon; Levon M. Khachigian; Harry C. Lowe

doi:10.1160/TH05-07-0514

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 2006; 96(05): 602-610
DOI: 10.1160/TH05-07-0514

Review Article

Schattauer GmbH

Rat models of myocardial infarction

Pathogenetic insights and clinical relevance

Ravinay Bhindi

¹Vascular Biology Laboratory, Anzac Research Institute, University of Sydney and Cardiology Department, Concord Repatriation General Hospital, New South Wales, Australia

²Centre for Vascular Research, School of Medical Sciences, University of New South Wales, Australia

,

Paul K. Witting

¹Vascular Biology Laboratory, Anzac Research Institute, University of Sydney and Cardiology Department, Concord Repatriation General Hospital, New South Wales, Australia

,

Aisling C. McMahon

¹Vascular Biology Laboratory, Anzac Research Institute, University of Sydney and Cardiology Department, Concord Repatriation General Hospital, New South Wales, Australia

,

Levon M. Khachigian

²Centre for Vascular Research, School of Medical Sciences, University of New South Wales, Australia

,

Harry C. Lowe

¹Vascular Biology Laboratory, Anzac Research Institute, University of Sydney and Cardiology Department, Concord Repatriation General Hospital, New South Wales, Australia

²Centre for Vascular Research, School of Medical Sciences, University of New South Wales, Australia

› Author Affiliations

Abstract

Summary

Animal models of cardiovascular pathology contribute towards understanding and treatment of a broad range of conditions. Specifically in the context of acute myocardial infarction (AMI), rat models have been commonly used in studies of pathogenesis, investigation and novel therapies, although there has often been difficulty in translating experimental findings to clinical benefit. However, recent years have seen two important changes to our clinical approaches to AMI. First, there is increasing recognition that the pathophysiology of human AMI is a process occurring at many levels, not just within the epicardial coronary artery, but also within the microvasculature and the myocardium. Second, contemporary treatments are shifting away from thrombolytic dissolution of epicardial coronary thrombus to direct mechanical approaches using angioplasty and stents. These changes in our understanding of AMI have implications for the relevance of these animal models. The following discussion therefore reviews and examines the current rat models of AMI, places them in a clinical context, discusses their advantages and limitations, and outlines likely future developments, providing an overview of the place of these important models of AMI.

Keywords

Rat - animal model - myocardial infarction - microvasculature

Full Text

References

References
1 Ryan TJ, Anderson JL, Antman EM. et al. ACC/ AHA guidelines for the management of patients with acute myocardial infarction: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). Circulation 1996; 94: 2341-50.
2 Lowe HC, Neill BD, Van de Werf F. et al. Pharmacologic reperfusion therapy for acute myocardial infarction. J Thromb Thrombolysis 2002; 14: 179-96.
3 Topol EJ. Acute myocardial infarction: thrombolysis. Heart 2000; 83: 122-6.
4 DeWood MA, Spores J, Notske R. et al. Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction. N Engl J Med 1980; 303: 897-902.
5 Davies MJ, Robertson WB, Woolf N. et al. Pathogenesis of myocardial infarction. Am Heart J 1978; 96: 561-3.
6 Boersma E, Mercado N, Poldermans D. et al. Acute myocardial infarction. Lancet 2003; 361: 847-58.
7 Simes RJ, Topol EJ, Holmes Jr. DR. et al. Link between the angiographic substudy and mortality outcomes in a large randomized trial of myocardial reperfusion. Importance of early and complete infarct artery reperfusion. GUSTO-I Investigators. Circulation 1995; 91: 1923-8.
8 Stone GW, Grines CL, Cox DA. et al. Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction. N Engl J Med 2002; 346: 957-66.
9 Ito H, Okamura A, Iwakura K. et al. Myocardial perfusion patterns related to thrombolysis in myocardial infarction perfusion grades after coronary angioplasty in patients with acute anterior wall myocardial infarction. Circulation 1996; 93: 1993-9.
10 Sakuma T, Hayashi Y, Sumii K. et al. Prediction of short- and intermediate-term prognoses of patients with acute myocardial infarction using myocardial contrast echocardiography one day after recanalization. J Am Coll Cardiol 1998; 32: 890-7.
11 Porter TR, Li S, Oster R. et al. The clinical implications of no reflow demonstrated with intravenous perfluorocarbon containing microbubbles following restoration of Thrombolysis In Myocardial Infarction (TIMI) 3 flow in patients with acute myocardial infarction. Am J Cardiol 1998; 82: 1173-7.
12 Rezkalla SH, Kloner RA. No-reflow phenomenon. Circulation 2002; 105: 656-62.
13 Krug A, Du Mesnil de R, Korb G. Blood supply of the myocardium after temporary coronary occlusion. Circ Res 1966; 19: 57-62.
14 Kloner RA, Ganote CE, Jennings RB. The “no-reflow” phenomenon after temporary coronary occlusion in the dog. J Clin Invest 1974; 54: 1496-508.
15 Manciet LH, Poole DC, McDonagh PF. et al. Microvascular compression during myocardial ischemia: mechanistic basis for no-reflow phenomenon. Am J Physiol 1994; 266: H1541-50.
16 Hearse DJ, Maxwell L, Saldanha C. et al. The myocardial vasculature during ischemia and reperfusion: a target for injury and protection. J Mol Cell Cardiol 1993; 25: 759-800.
17 Eeckhout E, Kern MJ. The coronary no-reflow phenomenon: a review of mechanisms and therapies. Eur Heart J 2001; 22: 729-39.
18 VanBenthuysen KM, McMurtry IF, Horwitz LD. Reperfusion after acute coronary occlusion in dogs impairs endothelium-dependent relaxation to acetylcholine and augments contractile reactivity in vitro . J Clin Invest 1987; 79: 265-74.
19 Malliani A, Schwartz PJ, Zanchetti A. A sympathetic reflex elicited by experimental coronary occlusion. Am J Physiol 1969; 217: 703-9.
20 Seydoux C, Goy JJ, Davies G. Platelet and neutrophil imaging techniques in the investigation of the response to thrombolytic therapy and the no-reflow phenomenon. Am Heart J 1993; 125: 1142-7.
21 Cannon 3rd RO. Mechanisms, management and future directions for reperfusion injury after acute myocardial infarction. Nat Clin Pract Cardio vasc Med 2005; 02: 88-94.
22 Angelini A, Rubartelli P, Mistrorigo F. et al. Distal protection with a filter device during coronary stenting in patients with stable and unstable angina. Circulation 2004; 110: 515-21.
23 Limbruno U, Micheli A, De Carlo M. et al. Mechanical prevention of distal embolization during primary angioplasty: safety, feasibility, and impact on myocardial reperfusion. Circulation 2003; 108: 171-6.
24 Dahm JB, Ebersole D, Das T. et al. Prevention of distal embolization and no-reflow in patients with acute myocardial infarction and total occlusion in the infarct-related vessel: a subgroup analysis of the cohort of acute revascularization in myocardial infarction with excimer laser-CARMEL multicenter study. Catheter Cardio vasc Interv 2005; 64: 67-74.
25 Akbar OAli, Bhindi R, McMahon A. et al. Distal Protection in Cardiovascular Medicine: Current Status. Am HeartJ 2006; 152: 207-16.
26 Fuster V, Moreno PR, Fayad ZA. et al. Atherothrombosis and high-risk plaque: part I: evolving concepts. J Am Coll Cardiol 2005; 46: 937-54.
27 Wayman NS, McDonald MC, Chatterjee PK. et al. Models of coronary artery occlusion and reperfusion for the discovery of novel antiischemic and antiinflammatory drugs for the heart. Methods Mol Biol 2003; 225: 199-208.
28 Liu YH, Yang XP, Nass O. et al. Chronic heart failure induced by coronary artery ligation in Lewis inbred rats. Am J Physiol Heart Circ Physiol 1997; 272: H722-727.
29 Chimenti S, Carlo E, Masson S. et al. Myocardial infarction: animal models. Methods Mol Med 2004; 98: 217-26.
30 Li RK, Jia ZQ, Weisel RD. et al. Smooth muscle cell transplantation into myocardial scar tissue improves heart function. J Mol Cell Cardiol 1999; 31: 513-22.
31 Rona G, Chappel CI, Balazs T. et al. An infarct-like myocardial lesion and other toxic manifestations produced by isoproterenol in the rat. AMA Arch Pathol 1959; 67: 443-55.
32 Medvedev OS, Gorodetskaya EA. Systemic and regional hemodynamic effects of perindopril in experimental heart failure. Am Heart J 1993; 126: 764-9.
33 Urasawa K, Sakai H, Saito T. et al. Wire-induced myocardial ischemia: a novel approach to create myocardial ischemia in rats. Circ J 2004; 68: 371-5.
34 Adler N, Camin LL, Shulkin P. Rat model for acute myocardial infarction: application to technetium-labeled glucoheptonate, tetracycline, and polyphosphate. J Nucl Med 1976; 17: 203-7.
35 Selye H, Bajusz E, Grasso S. et al. Simple techniques for the surgical occlusion of coronary vessels in the rat. Angiology 1960; 11: 398-407.
36 Anversa P, Beghi C, Kikkawa Y. et al. Myocardial infarction in rats. Infarct size, myocyte hypertrophy, and capillary growth. Circ Res 1986; 58: 26-37.
37 Anversa P, Beghi C, Kikkawa Y. et al. Myocardial response to infarction in the rat. Morphometric measurement of infarct size and myocyte cellular hypertrophy. Am J Pathol 1985; 118: 484-92.
38 Johns TN, Olson BJ. Experimental myocardial infarction. I. A method of coronary occlusion in small animals. Ann Surg 1954; 140: 675-82.
39 Himori N, Matsuura A. A simple technique for occlusion and reperfusion of coronary artery in conscious rats. Am J Physiol 1989; 256: H1719-25.
40 Kompa AR, Summers RJ. Lidocaine and surgical modification reduces mortality in a rat model of cardiac failure induced by coronary artery ligation. J Pharmacol Toxicol Methods 2000; 43: 199-203.
41 Ye J, Yang L, Sethi R. et al. A new technique of coronary artery ligation: experimental myocardial infarction in rats in vivo with reduced mortality. Mol Cell Biochem 1997; 176: 227-33.
42 Pfeffer MA, Pfeffer JM, Fishbein MC. et al. Myocardial infarct size and ventricular function in rats. Circ Res 1979; 44: 503-12.
43 Spadaro J, Fishbein MC, Hare C. et al. Characterization of myocardial infarcts in the rat. Arch Pathol Lab Med 1980; 104: 179-83.
44 Schwarz ER, Somoano Y, Hale SL. et al. What is the required reperfusion period for assessment of myocardial infarct size using triphenyltetrazolium chloride staining in the rat?. J Thromb Thrombolysis 2000; 10: 181-7.
45 Park SW, Lee SY, Park SJ. et al. Quantitative assessment of infarct size in vivo by myocardial contrast echocardiography in a murine acute myocardial infarction model. Int J Cardiol 2004; 97: 393-8.
46 Camilleri JP, Joseph D, Fabiani JN. et al. Microcirculatory changes following early reperfusion in experimental myocardial infarction. Virchows Arch A Pathol Anat Histol 1976; 369: 315-33.
47 Reffelmann T, Hale SL, Dow JS. et al. No-reflow phenomenon persists long-term after ischemia/reperfusion in the rat and predicts infarct expansion. Circulation 2003; 108: 2911-7.
48 Camilleri JP, Joseph D, Fabiani JN. et al. Experimental myocardial infarction in the rat as a quantitative model for the study of anti-ischemic interventions. Pathol Res Pract 1981; 172: 42-52.
49 Fishbein MC, Maclean D, Maroko PR. Experimental myocardial infarction in the rat: qualitative and quantitative changes during pathologic evolution. Am J Pathol 1978; 90: 57-70.
50 Fishbein MC, Maclean D, Maroko PR. The histopathologic evolution of myocardial infarction. Chest 1978; 73: 843-9.
51 Joseph D, Fabiani JN, Camilleri JP. Pathological patterns of reperfused myocardial infarction. Experimental study (author’s transl). Pathol Biol (Paris) 1980; 28: 160-7.
52 Hochman JS, Choo H. Limitation of myocardial infarct expansion by reperfusion independent of myocardial salvage. Circulation 1987; 75: 299-306.
53 Hale SL, Kloner RA. Left ventricular topographic alterations in the completely healed rat infarct caused by early and late coronary artery reperfusion. Am Heart J 1988; 116: 1508-13.
54 Bolli R, Jeroudi MO, Patel BS. et al. Direct evidence that oxygen-derived free radicals contribute to postischemic myocardial dysfunction in the intact dog. Proc Natl Acad Sci USA 1989; 86: 4695-9.
55 Bolli R, Jeroudi MO, Patel BS. et al. Marked reduction of free radical generation and contractile dysfunction by antioxidant therapy begun at the time of reperfusion. Evidence that myocardial “stunning” is a manifestation of reperfusion injury. Circ Res 1989; 65: 607-22.
56 Cordis GA, Maulik N, Bagchi D. et al. Estimation of the extent of lipid peroxidation in the ischemic and reperfused heart by monitoring lipid metabolic products with the aid of high-performance liquid chromatography. J Chromatogr 1993; 632: 97-103.
57 Eaton P, Li JM, Hearse DJ. et al. Formation of 4-hydroxy-2-nonenal-modified proteins in ischemic rat heart. Am J Physiol 1999; 276: H935-43.
58 Witting PK, Upston JM, Stocker R. The molecular action of alpha-tocopherol in lipoprotein lipid peroxidation. Pro- and antioxidant activity of vitamin E in complex heterogeneous lipid emulsions. Subcell Biochem 1998; 30: 345-90.
59 Darley-Usmar VM, O’Leary V, Stone D. The glutathione status of perfused rat hearts subjected to hypoxia and reoxygenation: the oxygen paradox. Free Radic Res Commun 1989; 06: 261-7.
60 Witting PK, Mohr D, Stocker R. Assessment of prooxidant activity of vitamin E in human low-density lipoprotein and plasma. Methods Enzymol 1999; 299: 362-75.
61 Ikeda Y, Umemura K. A characterization of myocardial infarction induced by thrombotic occlusion and a comparison with mechanical ligation of the rat coronary artery. Methods Find Exp Clin Pharmacol 2001; 23: 23-8.
62 Kurz KD, Main BW, Sandusky GE. Rat model of arterial thrombosis induced by ferric chloride. Thromb Res 1990; 60: 269-80.
63 Lockyer S, Kambayashi J. Demonstration of flow and platelet dependency in a ferric chloride-induced model of thrombosis. J Cardiovasc Pharmacol 1999; 33: 718-25.
64 Matsuno H, Uematsu T, Nagashima S. et al. Photochemically induced thrombosis model in rat femoral artery and evaluation of effects of heparin and tissue-type plasminogen activator with use of this model. J Pharmacol Methods 1991; 25: 303-17.
65 Anversa P, Zhang X, Li P. et al. Chronic coronary artery constriction leads to moderate myocyte loss and left ventricular dysfunction and failure in rats. J Clin Invest 1992; 89: 618-29.
66 Capasso JM, Jeanty MW, Palackal T. et al. Ventricular remodeling induced by acute nonocclusive constriction of coronary artery in rats. Am J Physiol 1989; 257: H1983-93.
67 Huwer H, Nikoloudakis N, Rissland J. et al. In vivo analysis of microvascular injury after myocardial cryothermia. J Surg Res 1998; 79: 1-7.
68 Ciulla MM, Paliotti R, Ferrero S. et al. Left ventricular remodeling after experimental myocardial cryoinjury in rats. J Surg Res 2004; 116: 91-7.
69 Gorodetskaya EA, Dugin SF, Medvedev OS. et al. Simple method to produce acute heart failure by coronary vessel embolization in closed chest rats with microspheres. J Pharmacol Methods 1990; 24: 43-51.
70 Teerlink JR, Pfeffer JM, Pfeffer MA. Progressive ventricular remodeling in response to diffuse isoproterenol-induced myocardial necrosis in rats. Circ Res 1994; 75: 105-13.
71 Tarnavski O, McMullen JR, Schinke M. et al. Mouse cardiac surgery: comprehensive techniques for the generation of mouse models of human diseases and their application for genomic studies. Physiol Genomics 2004; 16: 349-60.
72 Degabriele NM, Griesenbach U, Sato K. et al. Critical appraisal of the mouse model of myocardial infarction. Exp Physiol 2004; 89: 497-505.
73 Lutgens E, Daemen MJ, de Muinck ED. et al. Chronic myocardial infarction in the mouse: cardiac structural and functional changes. Cardiovasc Res 1999; 41: 586-93.
74 Dewald O, Frangogiannis NG, Zoerlein MP. et al. A murine model of ischemic cardiomyopathy induced by repetitive ischemia and reperfusion. Thorac Cardiovasc Surg 2004; 52: 305-11.
75 Nossuli TO, Lakshminarayanan V, Baumgarten G. et al. A chronic mouse model of myocardial ischemiareperfusion: essential in cytokine studies. Am J Physiol Heart Circ Physiol 2000; 278: H1049-55.
76 Michael LH, Entman ML, Hartley CJ. et al. Myocardial ischemia and reperfusion: a murine model. Am J Physiol 1995; 269: H2147-54.
77 Dewald O, Ren G, Duerr GD. et al. Of mice and dogs: species-specific differences in the inflammatory response following myocardial infarction. Am J Pathol 2004; 164: 665-77.
78 Deten A, Volz HC, Briest W. et al. Cardiac cytokine expression is upregulated in the acute phase after myocardial infarction. Experimental studies in rats. Cardiovasc Res 2002; 55: 329-40.
79 Hirata Y, Umemura K, Uematsu T. et al. An experimental myocardial infarction model in the rat and its properties. Jpn J Pharmacol 1995; 67: 51-7.
80 Tang YL. Autologous mesenchymal stem cells for post-ischemic myocardial repair. Methods Mol Med 2005; 112: 183-92.
81 Anversa P, Kajstura J, Leri A. et al. Life and death of cardiac stem cells. A paradigm shift in cardiac biology. Circulation 2006; 113: 1451-63.
82 Baker JE, Konorev EA, Gross GJ. et al. Resistance to myocardial ischemia in five rat strains: is there a genetic component of cardioprotection?. Am J Physiol Heart Circ Physiol 2000; 278: H1395-400.